Buchumschlag

BCL‐2 Inhibitor Regulates Number, Function, and Antitumor Immunity of T Cells by Influencing Glycolysis in AML

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Xiaohuan Peng, Yanhong Li, Futian Tang, Yanling Ma, Jun Bai, Lijuan Li, Liansheng Zhang
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Cancer Science
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

SLPI / FBW7 /c‐Myc Axis Reduces Gemcitabine Sensitivity in PDAC by Enhancing Glycolysis and Impairing NK Cell Immunity
von: Haofei Chen, et al.
Veröffentlicht: (2026)

PC4 Potentially Predicts Chemoradiation‐Induced Antitumor Immunity in Esophageal Squamous Cell Carcinoma
von: Jieyong Tian, et al.
Veröffentlicht: (2025)

Ezh2 Inhibits the Differentiation of Short‐Lived Effector CD8 + T Cells and Promotes T Cell‐Dependent Antitumor Immunity
von: Kenji Takagi, et al.
Veröffentlicht: (2026)

TGF ‐β Inhibitor Potentiates Osimertinib‐Induced Anti‐Tumor Immunity in Egfr ‐Mutant Lung Cancer
von: Tadahiro Kuribayashi, et al.
Veröffentlicht: (2026)

IGFBP2 Promotes Proliferation and Glycolysis of Endometrial Cancer by Regulating PKM2/HIF‐1α Axis
von: Yuxi Jin, et al.
Veröffentlicht: (2025)

The prognostic significance of MYC/BCL2 double expression in DLBCL in the genetic classification era
von: Yi‐Fan Wu, et al.
Veröffentlicht: (2024)

The LGALS9 / miR ‐491‐5p Axis Regulates CD8 + T Cell Function and Inhibits the Progression of Gastric Cancer
von: Wanzhong Huang, et al.
Veröffentlicht: (2025)

CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5 ‐Mediated Glutamine Metabolism Through YY1
von: Zihua Zhou, et al.
Veröffentlicht: (2026)

Pimitespib, an HSP90 Inhibitor, Enhances the Efficacy of PARP Inhibitors in PARP Inhibitor‐Insensitive Breast Cancer Cells
von: Hiromi Muraoka, et al.
Veröffentlicht: (2025)

Ligand‐Based CAR‐T Cells Targeting EGFR Exhibit Favorable Antitumor Effects Against Gynecologic Malignancies
von: Manaka Shinagawa, et al.
Veröffentlicht: (2025)

Antitumor activity of α‐pinene in T‐cell tumors
von: Masaya Abe, et al.
Veröffentlicht: (2024)

Antitumor host immunity enhanced by near‐infrared photoimmunotherapy
von: Hiroshi Fukushima, et al.
Veröffentlicht: (2024)

MAPK Inhibitor‐Tolerant Persister Cells in Melanoma: Mechanisms and Therapeutic Vulnerabilities
von: Bhoomi Shah, et al.
Veröffentlicht: (2026)

APE1 Attenuates ALK Tyrosine Kinase Inhibitors Sensitivity in NPM1‐ALK Positive Anaplastic Large Cell Lymphoma
von: Zheng Liu, et al.
Veröffentlicht: (2025)

Bispecific Ligand‐Based EphB4 CAR‐T Cells Generated Using Ephrin‐B2 Show Potent Antitumor Activity Against Lung Adenocarcinoma
von: Hirotaka Kumeda, et al.
Veröffentlicht: (2026)

Activation of cGAS ‐ STING Pathway by DAI ‐Triggered Ferroptosis in CRC Cells Reprograms TAMs Balance to Promote Anti‐Tumor Immunity
von: Pengrui Cheng, et al.
Veröffentlicht: (2025)

Blocking SETD2 Enhances the Therapeutic Efficiency of Menin Inhibitor in MLL ‐Fusion Leukemia
von: Anpei Li, et al.
Veröffentlicht: (2026)

Combination of LowDose Epigenetic Modifiers and TIC10 for the Activation of Antitumor Immunity and Inhibition of Tumor Growth in Gastrointestinal Cancer
von: Jianling Zou, et al.
Veröffentlicht: (2025)

Oncolytic Vaccinia Virus‐ HSP70 ‐ shRNA Amplifies Viral Replication, ROS /Autophagy, and Immunity to Fight Colorectal Cancer
von: Rentao Yuan, et al.
Veröffentlicht: (2026)

Docetaxel‐Induced Immune Activation Shows Antitumor Synergy With the Tumor‐Targeted CD40 Agonist KK2269
von: Yuta Tezuka, et al.
Veröffentlicht: (2026)

cGAS–STING Pathway Activation Enhances Antitumor Effect of Talaporfin Photodynamic Therapy Through ROS Production
von: Makiko Sasaki, et al.
Veröffentlicht: (2025)

RETRACTION : MicroRNA ‐16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor‐ κB1 / MMP9 signaling pathway
Veröffentlicht: (2024)

Lnc‐TPT1‐AS1/CBP/ATIC Axis Mediated Purine Metabolism Activation Promotes Breast Cancer Progression
von: Yiyun Zhang, et al.
Veröffentlicht: (2025)

GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A
von: Hui‐min Zhang, et al.
Veröffentlicht: (2025)

JI ‐ CJ002 and Dabrafenib Combination Enhances Antitumor Activity in Melanoma Associated With the Downregulation of B7 ‐ H3
von: Sang‐Eun Lee, et al.
Veröffentlicht: (2026)

Antitumor Activities by a Humanized Cancer‐Specific Anti‐Podoplanin Monoclonal Antibody humPMab‐117 Against Human Tumors
von: Tomohiro Tanaka, et al.
Veröffentlicht: (2025)

HROB Induces Lung Adenocarcinoma Progression via ZC3HC1‐CCNB1 Axis Regulation and Cell Cycle Dysregulation
von: Zhe Zhang, et al.
Veröffentlicht: (2025)

Evans Blue Acts as a Selective Inhibitor of CaMKII‐α to Impede the Progression of TCL Identified by HTS
von: Jianru Tian, et al.
Veröffentlicht: (2025)

Impact of Sequential Ramucirumab Plus Docetaxel After PD ‐1 Inhibitors on Anti‐ PD ‐1 Antibody‐Bound T‐Cell Dynamics and Clinical Outcomes
von: Kinnosuke Matsumoto, et al.
Veröffentlicht: (2026)

Exploring Long Noncoding RNAs as Regulators of Tumor Ferroptosis: Advances and Challenges
von: Gang Li, et al.
Veröffentlicht: (2025)

Synergistic Antitumor Activity of HAT Inhibitor A485 and XPO1 Inhibitor KPT8602 in Multiple Myeloma
von: Hong Xu, et al.
Veröffentlicht: (2026)

Tumor Anti‐Angiogenesis Therapy and Its Influence on Immune Cell Function in the Tumor Microenvironment
von: Yu Tang, et al.
Veröffentlicht: (2026)

Single‐Cell Transcriptomics Identifies Novel Prognostic Signatures in HNSCC Immunotherapy Response
von: Kankui Wu, et al.
Veröffentlicht: (2025)

Dual Role of LBH589 in Triple‐Negative Breast Cancer: Inhibition of Tumor Growth and Enhancement of Antitumor Immunity
von: Liang Anjing, et al.
Veröffentlicht: (2026)

SOD2 ‐Superoxide Metabolic Axis Regulates Mitophagy and Modulates TKIs Sensitivity in Head and Neck Squamous Cell Carcinoma
von: Wan‐Hang Zhou, et al.
Veröffentlicht: (2026)

Insights From Nonsense‐Mediated mRNA Decay for Prognosis in Homologous Recombination‐Deficient Ovarian Cancer
von: Lei Han, et al.
Veröffentlicht: (2025)

Cytoplasmic Vacuolization: A Fascinating Morphological Alteration From Cellular Stress to Cell Death
von: Xiaoxu Wen, et al.
Veröffentlicht: (2025)

HTLV ‐1 Tax Reshapes the DNA ‐Binding Pattern of Transcription Factor IRF4 and Disrupts Host Gene Regulation
von: Shu Tosaka, et al.
Veröffentlicht: (2026)

T Cell Heterogeneity Shaped by Alternative Splicing Predicts Prognosis in Hepatocellular Carcinoma
von: Xiaohui Peng, et al.
Veröffentlicht: (2026)

Resveratrol as a Novel YAP Inhibitor Targeting Glioblastoma Progression and Sensitizing to Chemotherapy
von: Wannawat Khotchawan, et al.
Veröffentlicht: (2026)